Abstract
Platelets are a critical cell for prevention of bleeding. Part of the response to the formation of the thrombus is the activation of the actin cytoskeleton, with an inability to effectively activate the cytoskeleton linked to thrombus formation defects and instability. The control of this process is linked to activation of the Rho GTPases, Cdc42, Rac1, and RhoA, although additional small GTPases such as Rif and Rap have been shown to play roles in platelet function.
Here we describe the methodology to accurately understand how Rho GTPases are activated in platelets. Due to the technical limitations of working with platelets, such as their lack of ability to be transfected, the majority of work has been carried out either using inhibitors of Rho GTPases or within knockout mouse models. Studies can be conducted both in suspension samples and in spread platelets. In suspension the platelets will undergo a shape change response, but will not be able to spread. In spread platelets it is possible to examine the effects of the matrix environment, such as concentration, type, and stiffness on Rho GTPase function within platelet activation and platelet spreading.
Key words
- Actin
- RhoA
- Rac1
- Platelets
- cAMP
- cGMP
- Pull-down assay
- Y27632
- Rhosin A
This is a preview of subscription content, access via your institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Aslan JE, McCarty OJ (2013) Rho GTPases in platelet function. J Thromb Haemost 11:35–46
Hodge RG, Ridley AJ (2016) Regulating Rho GTPases and their regulators. Nat Rev Mol Cell Biol 17:496–510
Akbar H, Shang X, Perveen R, Berryman M, Funk K, Johnson JF, Tandon NN, Zheng Y (2011) Gene targeting implicates Cdc42 GTPase in GPVI and non-GPVI mediated platelet filopodia formation, secretion and aggregation. PLoS One 6:e22117
Pleines I, Eckly A, Elvers M, Hagedorn I, Eliautou S, Bender M, Wu X, Lanza F, Gachet C, Brakebusch C, Nieswandt B (2010) Multiple alterations of platelet functions dominated by increased secretion in mice lacking Cdc42 in platelets. Blood 115:3364–3373
Goggs R, Savage JS, Mellor H, Poole AW (2013) The small GTPase Rif is dispensable for platelet filopodia generation in mice. PLoS One 8:e54663
McCarty OJ, Larson MK, Auger JM, Kalia N, Atkinson BT, Pearce AC, Ruf S, Henderson RB, Tybulewicz VL, Machesky LM, Watson SP (2005) Rac1 is essential for platelet lamellipodia formation and aggregate stability under flow. J Biol Chem 280:39474–39484
Aburima A, Wraith KS, Raslan Z, Law R, Magwenzi S, Naseem KM (2013) cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway. Blood 122:3533–3545
Calaminus SD, Auger JM, McCarty OJ, Wakelam MJ, Machesky LM, Watson SP (2007) MyosinIIa contractility is required for maintenance of platelet structure during spreading on collagen and contributes to thrombus stability. J Thromb Haemost 5:2136–2145
Paul BZ, Daniel JL, Kunapuli SP (1999) Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 rho-associated coiled-coil-containing protein kinase in platelet shape change. J Biol Chem 274:28293–28300
Calaminus SD, Thomas S, McCarty OJ, Machesky LM, Watson SP (2008) Identification of a novel, actin-rich structure, the actin nodule, in the early stages of platelet spreading. J Thromb Haemost 6:1944–1952
Poulter NS, Pollitt AY, Davies A, Malinova D, Nash GB, Hannon MJ, Pikramenou Z, Rappoport JZ, Hartwig JH, Owen DM, Thrasher AJ, Watson SP, Thomas SG (2015) Platelet actin nodules are podosome-like structures dependent on Wiskott-Aldrich syndrome protein and ARP2/3 complex. Nat Commun 6:7254
Aslan JE, Tormoen GW, Loren CP, Pang J, McCarty OJ (2011) S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation. Blood 118:3129–3136
Yusuf MZ, Raslan Z, Atkinson L, Aburima A, Thomas SG, Naseem KM, Calaminus SDJ (2017) Prostacyclin reverses platelet stress fibre formation causing platelet aggregate instability. Sci Rep 7:5582
Thornber K, McCarty OJ, Watson SP, Pears CJ (2006) Distinct but critical roles for integrin αIIbβ3 in platelet lamellipodia formation on fibrinogen, collagen-related peptide and thrombin. FEBS J 273:5032–5043
Roberts W, Magwenzi S, Aburima A, Naseem KM (2010) Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade. Blood 116:4297–4306
Nergiz-Unal R, Lamers MM, Van Kruchten R, Luiken JJ, Cosemans JM, Glatz JF, Kuijpers MH, Heemskerk JW (2011) Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low-density lipoprotein. J Thromb Haemost 9:1835–1846
McCarty OJ, Calaminus SD, Berndt MC, Machesky LM, Watson SP (2006) von Willebrand factor mediates platelet spreading through glycoprotein Ib and αIIbβ3 in the presence of botrocetin and ristocetin, respectively. J Thromb Haemost 4:1367–1378
Inoue O, Suzuki-Inoue K, Dean WL, Frampton J, Watson SP (2003) Integrin α2β1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCγ2. J Cell Biol 160:769–780
Inoue O, Suzuki-Inoue K, McCarty OJ, Moroi M, Ruggeri ZM, Kunicki TJ, Ozaki Y, Watson SP (2006) Laminin stimulates spreading of platelets through integrin α6β1-dependent activation of GPVI. Blood 107:1405–1412
Alshehri OM, Hughes CE, Montague S, Watson SK, Frampton J, Bender M, Watson SP (2015) Fibrin activates GPVI in human and mouse platelets. Blood 126:1601–1608
Qiu Y, Brown AC, Myers DR, Sakurai Y, Mannino RG, Tran R, Ahn B, Hardy ET, Kee MF, Kumar S, Bao G, Barker TH, Lam WA (2014) Platelet mechanosensing of substrate stiffness during clot formation mediates adhesion, spreading, and activation. Proc Natl Acad Sci U S A 111:14430–14435
Kee MF, Myers DR, Sakurai Y, Lam WA, Qiu Y (2015) Platelet mechanosensing of collagen matrices. PLoS One 10:e0126624
Faure J, Dagher MC (2001) Interactions between Rho GTPases and Rho GDP dissociation inhibitor (Rho-GDI). Biochimie 83:409–414
Naseem KM, Goodall AH, Bruckdorfer KR (1997) Differential effects of native and oxidatively modified low-density lipoproteins on platelet function. Platelets 8:163–173
Gerry AB, Satchell L, Leake DS (2008) A novel method for production of lipid hydroperoxide- or oxysterol-rich low-density lipoprotein. Atherosclerosis 197:579–587
el-Saadani M, Esterbauer H, el-Sayed M, Goher M, Nassar AY, Jurgens G (1989) A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 30:627–630
Magwenzi S, Woodward C, Wraith KS, Aburima A, Raslan Z, Jones H, McNeil C, Wheatcroft S, Yuldasheva N, Febbriao M, Kearney M, Naseem KM (2015) Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade. Blood 125:2693–2703
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Rivero, F., Calaminus, S. (2018). Methods to Study the Roles of Rho GTPases in Platelet Function. In: Rivero, F. (eds) Rho GTPases. Methods in Molecular Biology, vol 1821. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8612-5_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8612-5_14
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8611-8
Online ISBN: 978-1-4939-8612-5
eBook Packages: Springer Protocols